Skip to main content
Caplight Logo









Cortalix B.V.

Cortalix B.V.

Private
GroningenHealthcare & Life Scienceshttps://cortalix.com/

Last Round

Seed

Mar 3, 2025

Total Funding Raised

$1.09M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cortalix B.V. is a biotechnology company that specializes in the discovery and engineering of single-domain antibodies (VHH or nanobodies) for applications in molecular imaging, targeted therapy, and immunotherapy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

nanobodysingle-domain antibodyVHHradiopharmaceuticalsantibody discoverynanobody engineeringmolecular imagingtargeted therapybiotech CROcontract research organizationCROphage displayantibody libraryaffinity maturationdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cortalix B.V. Comparables

Compare Cortalix B.V. with similar companies based on industry and business-model similarity.

Cortalix B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sanofi
70%
GenScript
63%
Adimab
62%

Cortalix B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 3, 2025

Cortalix B.V. Investors

Notable investors and investment history

Cortalix B.V. investors
InvestorRounds
Innovatie Fonds RabobankSeed
Future Tech VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 12, 2026

    Monthly visitors grew 164% MoM, from 469 to 1.2K.

  • Apr 1, 2026

    Monthly visitors grew 410% MoM.

Cortalix B.V. Filings

Explore SEC and related filing metadata, where available.

Cortalix B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cortalix B.V.'s valuation, stock price, and market status.

Is Cortalix B.V. a public or private company?

Cortalix B.V. is a private company.

What is the current stock price of Cortalix B.V.?

Cortalix B.V. is a private company, so its shares have no public market price. Caplight tracks Cortalix B.V.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cortalix B.V. worth (valuation)?

Valuation information for Cortalix B.V. is not publicly available.

Can I buy Cortalix B.V. stock?

Cortalix B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cortalix B.V.'s last funding round?

Cortalix B.V.'s most recent funding round was Seed on March 3, 2025.

Who are the main investors in Cortalix B.V.?

Key investors in Cortalix B.V. include Future Tech Ventures.

Will Cortalix B.V. IPO soon?

No public IPO plans have been announced for Cortalix B.V..

How can I track Cortalix B.V. secondary market activity?

Caplight tracks bids, offers, and trades in Cortalix B.V.'s shares on secondary markets.

Firmographic Details

HeadquartersGroningen
Employee Range6
Year Founded2023
Last FundingMar 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?